Companies: 48,686 Total Market Cap: 127450980378181.95

U2Bio

KOSDAQ-221800

Medical Laboratories

Rank #33326

Market Cap 26.08 M

Volume 15.01

Price 4.83

Change (%) 0.00%

Country or region

South Korea

U2Bio's latest marketcap:

26.08 M

As of May 9, 2025, U2Bio's market capitalization has reached $26.08 M. According to our data, U2Bio is the 33326th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	26.08 M
Revenue (ttm)	0
Net Income (ttm)	0
Shares Out	11.29 M
EPS (ttm)	0
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	n/a

Market Cap Chart

Data Updated: May 9, 2025

U2Bio's yearly market capitalization.

U2Bio has seen its market value grow from ₩14.88 B to ₩36.68 B since 2020, representing a total increase of 146.51% and an annual compound growth rate (CAGR) of 23.00%.

Date	Market Cap	Change (%)
May 9, 2025	₩36.68 B	21.2%
December 30, 2024	₩30.08 B	-49.53%
December 28, 2023	₩59.60 B	20.84%
December 29, 2022	₩49.32 B	-12.03%
December 30, 2021	₩56.07 B	276.76%
December 30, 2020	₩14.88 B

Company Profile

About U2Bio Co., Ltd.

U2Bio Co., Ltd. is a South Korean healthcare company specializing in innovative medical and biotechnology solutions. Established in 2009 and headquartered in Seoul, the company delivers a range of services aimed at improving patient care and health outcomes.

Core Services

Clinical Laboratory Testing: Comprehensive diagnostic and testing services for accurate medical assessments.
Digital Healthcare Solutions: Technology-driven services for health examinations and testing, enhancing accessibility and efficiency.
Bio-Technology Platforms: Cutting-edge biotech tools and solutions to support research and healthcare advancements.

With a commitment to innovation, U2Bio Co., Ltd. continues to expand its contributions to the healthcare industry in South Korea and beyond.

Frequently Asked Questions

As of May 9, 2025, U2Bio (including the parent company, if applicable) has an estimated market capitalization of $26.08 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

U2Bio global market capitalization ranking is approximately 33326 as of May 9, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	South Korea
Founded	2009
IPO Date	n/a
Employees	n/a
CEO	Jin-Tae Kim
Sector
Industry	Medical Laboratories
Address	489, Ogeum-ro Seoul South Korea